AP: Fire at Laurus Pharma labs Parawada unit, 4 killed and 1 injured
Amarnath informed that the Chief Minister announced that compensation of Rs 25 lakh will be paid to the families of the deceased workers.;
Visakhapatnam: Four workers were killed while one was seriously injured in a flash fire that was reported in the API manufacturing plant of Laurus Pharma labs Limited in Andhra Pradesh's Anakapalli.
"We regret to inform you that on the evening of 26th December 2022 flash fire occurred in one of the rooms in one manufacturing block of our API manufacturing plant (Unit 3), Jawaharlal Nehru Pharma City, Parawada, Anakapally district, Visakhapatnam, Andhra Pradesh. The operations in the other production blocks are running normally," Laurus Labs informed in a BSE filing.
The deceased were identified as T Rajesh Babu, R Ram Krishna, B Rambabu, and M Venkata Rao, and the injured person was Y Satish, Leaders of CITU trade union told TOI.
"The incident happened while under maintenance works," the police said.
State Industries Minister Amarnath said that the injured worker is undergoing treatment at the hospital. The Minister has informed Chief Minister Jagan Mohan Reddy about the incident.
Amarnath directed the medical officials to provide medical aid to another worker who was seriously injured in the accident.
A probe to ascertain the cause of the accident has been ordered.
Read also: Fire at Chennai pharma production firm doused, no casualties reported
Laurus Labs is an Indian multinational pharmaceutical company headquartered in Hyderabad. The company was founded by Satyanarayana Chava in 2005. The company sells APIs in 56 countries. Its major focus areas include anti-retroviral, Hepatitis C, and Oncology drugs. The company's facilities have been certified and approved by WHO, USFDA, NIP Hungary, PMDA, KFDA and BfArM.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.